
|Articles|April 1, 2004
Q-switched combination laser provides option for treating hyperpigmentation
Dallas - A new Q-switched combination 532/1,064 Nd:YAG laser provides physicians with an option for treating postsclerotherapy hyperpigmentation, according to a presentation scheduled for the annual meeting of American Society for Laser Medicine and Surgery.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Lebrikizumab Earns FDA Approval for Less Frequent, Every-8-Week Maintenance Dosing in AD
4
Malassezia Folliculitis vs Acne Vulgaris: Key Diagnostic and Treatment Differences
5














